Morepen Laboratories (NSE:MOREPENLAB) Institutional Ownership: 1.29% (As of Jul. 06, 2026)


NSE:MOREPENLAB Morepen Laboratories Ltd NSE:MOREPENLAB
79 GF Score
Price ₹59.07
GF Value ₹49.90
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Morepen Laboratories Institutional Ownership?

Morepen Laboratories NSE:MOREPENLAB -1.20% 79 Institutional Ownership is 1.29% as of Jul. 06, 2026. GuruFocus rates NSE:MOREPENLAB with a GF Score™ of 79/100 and a GF Value™ of ₹49.90 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Morepen Laboratories's institutional ownership is 1.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Morepen Laboratories's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Morepen Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.

Morepen Laboratories Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Morepen Laboratories's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Morepen Laboratories Institutional Ownership Chart

Morepen Laboratories Historical Data

The historical data trend for Morepen Laboratories can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 1.32 1.31 1.32 1.29 1.28 1.29 1.28 1.28 1.29 1.29
NSE:MOREPENLAB
79GF Score
Morepen Laboratories Ltd NSE:MOREPENLAB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Morepen Laboratories Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.29% mean?
Morepen Laboratories (NSE:MOREPENLAB) has a Institutional Ownership of 1.29% as of Jul. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Morepen Laboratories and its competitors.
Is Morepen Laboratories' Institutional Ownership too high?
Morepen Laboratories' current Institutional Ownership is 1.29%. Overall, Morepen Laboratories has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Morepen Laboratories' Institutional Ownership compare to ZTS and UTHR?
Morepen Laboratories' Institutional Ownership of 1.29% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Morepen Laboratories and its competitors. Morepen Laboratories's current Institutional Ownership is 1.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morepen Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Morepen Laboratories (NSE:MOREPENLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹49.90, compared to a current price of ₹59.07 — trading 18.4% above its estimated fair value. The current Institutional Ownership is 1.29%. Morepen Laboratories' overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Morepen Laboratories (NSE:MOREPENLAB), the current Institutional Ownership is 1.29% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Morepen Laboratories (NSE:MOREPENLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Morepen Laboratories stock appears to be overvalued. The current stock price of ₹59.07 is trading 18.4% above its estimated GF Value™ of ₹49.90. GuruFocus considers Morepen Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:MOREPENLAB:

  • Institutional Ownership: 1.29%
  • GF Value™: ₹49.90 vs. price of ₹59.07 (18.4% above fair value)
  • GF Score™: 79/100 with 9 warning signs

No single metric tells the full story. See the NSE:MOREPENLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Morepen Laboratories Business Description

Other Exchanges 500288:India
Address Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
79GF Score

Get the complete analysis for NSE:MOREPENLAB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹59.07
Price
₹49.90
GF Value